Aeva Technologies, Inc. Common Stock (AEVA): Among the Tech Stocks That Are Up the Most So Far in 2025
Most tech stocks haven't been doing well so far this year, but this isn't a problem that all tech stocks face. The technology sector is broad, and there are always some stocks that still do well regardless of the broader market environment.
Many of these companies are leading the way in artificial intelligence, cloud computing, and cybersecurity. Their ability to adapt and launch new solutions has set them apart from the pack. For example, firms that reported robust growth in large customer contracts or unveiled breakthrough AI tools have seen their shares surge, even as industry giants have struggled with market volatility.
It's worth looking into these winners if you're looking for opportunities in this market.
For this article, I screened the best-performing tech stocks year-to-date.
I will also mention the number of hedge fund investors in these stocks. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A close-up of a LiDAR-on-chip sensor mounted in a consumer-grade electronic device.
Number of Hedge Fund Holders In Q4 2024: 11
Aeva Technologies, Inc. Common Stock (NASDAQ:AEVA) is a leader in next-generation sensing and perception systems that develops 4D LiDAR technology for autonomous vehicles, industrial robotics, and other applications.
The stock is up significantly so far in 2025 after securing a major development program award from a global top 10 passenger OEM for their next-generation production platform planned for multiple vehicle model lines. According to their March 2025 fourth quarter and full year 2024 results announcement, CEO Soroush Salehian said that 2025 would be a year of record revenues with significant growth while reducing spending.
Morgan Stanley boosted investor confidence by raising Aeva Technologies, Inc. Common Stock (NASDAQ:AEVA)'s price target to $5.22 from $4.87 in March 2025. The analyst recognized Aeva's product execution and highlighted a second major OEM win that showed the company's potential to become a significant market player. The stock received additional positive attention when Aeva announced in January 2025 its transfer from the NYSE to the Nasdaq Global Select Market effective January 28, 2025.
The consensus price target of $7.14 implies 13.4% upside.
AEVA stock is up 32.53% year-to-date.
Overall AEVA ranks 12th on our list of the tech stocks that are up the most so far in 2025. While we acknowledge the potential of AEVA as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than AEVA but that trades at less than 5 times its earnings, check out our report about this .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
iRhythm Technologies Second Quarter 2025 Earnings: Beats Expectations
iRhythm Technologies (NASDAQ:IRTC) Second Quarter 2025 Results Key Financial Results Revenue: US$186.7m (up 26% from 2Q 2024). Net loss: US$14.2m (loss narrowed by 29% from 2Q 2024). US$0.44 loss per share (improved from US$0.65 loss in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period iRhythm Technologies Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are up 23% from a week ago. Risk Analysis It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with iRhythm Technologies, and understanding this should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Despite lower earnings than a year ago, Five Below (NASDAQ:FIVE) investors are up 92% since then
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). To wit, the Five Below, Inc. (NASDAQ:FIVE) share price is 92% higher than it was a year ago, much better than the market return of around 18% (not including dividends) in the same period. That's a solid performance by our standards! In contrast, the longer term returns are negative, since the share price is 3.9% lower than it was three years ago. Although Five Below has shed US$303m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). During the last year, Five Below actually saw its earnings per share drop 10%. Given the share price gain, we doubt the market is measuring progress with EPS. Indeed, when EPS is declining but the share price is up, it often means the market is considering other factors. We think that the revenue growth of 11% could have some investors interested. Many businesses do go through a phase where they have to forgo some profits to drive business development, and sometimes its for the best. You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image). It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. So it makes a lot of sense to check out what analysts think Five Below will earn in the future (free profit forecasts). A Different Perspective It's nice to see that Five Below shareholders have received a total shareholder return of 92% over the last year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 5% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Five Below has 1 warning sign we think you should be aware of. But note: Five Below may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
BOK Financial Second Quarter 2025 Earnings: Beats Expectations
BOK Financial (NASDAQ:BOKF) Second Quarter 2025 Results Key Financial Results Revenue: US$535.3m (down 2.3% from 2Q 2024). Net income: US$138.5m (down 15% from 2Q 2024). Profit margin: 26% (down from 30% in 2Q 2024). The decrease in margin was primarily driven by higher expenses. EPS: US$2.19 (down from US$2.54 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period BOK Financial Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Looking ahead, revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Banks industry in the US. Performance of the American Banks industry. The company's shares are down 6.4% from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of BOK Financial's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. 登入存取你的投資組合
